COMPOSITIONS AND METHODS FOR ENHANCING NEUROGENESIS IN ANIMALS
The invention provides methods for enhancing neurogenesis in an animal. In one embodiment, a method for enhancing neurogenesis in an animal can comprise identifying an animal that is suffering from cognitive decline, that is at risk of becoming cognitively impaired, that is diagnosed with a disease, disorder, or other condition that affects its cognitive abilities, or that is at risk of contracting a disease, disorder, or other condition that affects its cognitive abilities, and administering a composition comprising an unsaturated fatty acid (UFA), a nitric oxide releasing compound (NORC), a B vitamin, and an antioxidant, to the animal, wherein the composition is administered in an amount effective for enhancing neurogenesis in the animal.
1 . A method for enhancing neurogenesis in an animal, comprising:
identifying an animal that is suffering from cognitive decline, that is at risk of becoming cognitively impaired, that is diagnosed with a disease, disorder, or other condition that affects its cognitive abilities, or that is at risk of contracting a disease, disorder, or other condition that affects its cognitive abilities, and
administering a composition comprising an unsaturated fatty acid (UFA), a nitric oxide releasing compound (NORC), a B vitamin, and an antioxidant, to the animal, wherein the composition is administered in an amount effective for enhancing neurogenesis in the animal.
2 . The method of claim 1 , wherein the neurogenesis occurs in the hippocampus in the animal and the neuron density is increased by at least 10%.
3 . The method of claim 1 , wherein the composition comprises from about 0.1% to about 50% UFA and wherein the UFA comprises one or more of a natural fish oil, ALA, EPA, DPA, DHA, or another n-3 fatty acid from any source.
4 . The method of claim 1 , wherein the composition comprises from about 0.1% to about 20% NORC and wherein the NORC is arginine, citrulline, ornithine, or a nitric oxide-releasing derivative thereof.
5 . The method of claim 1 , wherein the composition comprises from about 1,2 to 40 times the recommended daily requirement of the B vitamin and wherein the B vitamin is selected from the group consisting of vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B8, vitamin B9, vitamin B12, and mixtures thereof.
6 . The method of claim 1 , wherein the composition comprises from about 0.0001% to about 25% of the antioxidant and wherein the antioxidant is selected from any of the group consisting of carotenoids, flavonoids, phenolic acids and their esters, nonflavonoid phenolics, curcumin, flavonolignans, xanthones, eugenol, vitamin C, vitamin E, selenium, and mixtures thereof.
7 . The method of claim 1 , wherein the composition is formulated as a human food composition, pet food composition, or a dietary supplement.
8 . The method of claim 1 , wherein the animal has a phenotype associated with age-related cognitive impairment, wherein the phenotype includes one or more of decreased ability to recall, short-term memory loss, decreased learning rate, decreased capacity for learning, decreased problem solving skills, decreased attention span, decreased motor performance, increased confusion, or dementia, as compared to a control animal not having the phenotype.
9 . The method of claim 1 , wherein the animal is a healthy aging animal.
10 . The method of claim 1 , wherein the animal is a canine or a feline.
11 . A method for enhancing neurogenesis in a growing animal, comprising:
identifying the growing animal, and
administering a composition comprising an unsaturated fatty acid (UFA), a nitric oxide releasing compound (NORC), a B vitamin, and an antioxidant, to the growing animal, wherein the composition is administered in an amount effective for enhancing neurogenesis in the growing animal.
12 . The method of claim 11 , wherein the neurogenesis occurs in the hippocampus in the growing animal and the neuron density is increased by at least 10%.
13 . The method of claim 11 , wherein the composition comprises from about 0.1% to about 50% UFA and wherein the UFA comprises one or more of a natural fish oil, ALA, EPA, DPA, DHA, or another n-3 fatty acid from any source.
14 . The method of claim 11 , wherein the composition comprises from about 0.1% to about 20% NORC and wherein the NORC is arginine, citrulline, ornithine, or a nitric oxide-releasing derivative thereof.
15 . The method of claim 11 , wherein the composition comprises from about 1,2 to 40 times the recommended daily requirement of the B vitamin and wherein the B vitamin is selected from the group consisting of vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B8, vitamin B9, vitamin B12, and mixtures thereof.
16 . The method of claim 11 , wherein the composition comprises from about 0.0001% to about 25% of the antioxidant and wherein the antioxidant is selected from any of the group consisting of carotenoids, flavonoids, phenolic acids and their esters, nonflavonoid phenolics, curcumin, flavonolignans, xanthones, eugenol, vitamin C, vitamin E, selenium, and mixtures thereof.
17 . The method of claim 11 , wherein the composition is formulated as a human food composition, pet food composition, or a dietary supplement.
18 . The method of claim 11 , wherein the growing animal has reached a life expectancy between 0 and 30%.
19 . The method of claim 11 , wherein the growing animal is an infant, a kitten, or a puppy.
20 . The method of claim 11 , wherein the composition includes arginine, fish oil, B vitamins, vitamin E, vitamin C, astaxanthin, and selenium.